Cellectis (CLLS) Prepaid Assets (2014 - 2026)
Cellectis (CLLS) recorded quarterly Prepaid Assets of $6.1 million in Q1 2026, up 14.1% quarter-over-quarter from $5.4 million in Q4 2025, and up 19.33% on a YoY basis from $5.1 million in Q1 2025.
Cellectis (CLLS) Prepaid Assets (2014 - 2026) Analysis & Trends
Cellectis' Prepaid Assets history runs 13 years deep, the most recent figure standing at $6.1 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 19.33% year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at $6.1 million (up 19.33% YoY), while the FY2025 annual figure was $5.4 million, down 2.62% from the prior year.
- Prepaid Assets was $6.1 million for Q1 2026 at Cellectis, up from $5.4 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $9.7 million in Q1 2023 to a low of $4.5 million in Q3 2025.
- Historically, Prepaid Assets has averaged $6.8 million across 5 years, with a median of $6.6 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets tumbled 66.19% in 2022, then grew 28.96% in 2023.
- A 5-year view of Prepaid Assets shows it stood at $6.2 million in 2022, then retreated by 8.29% to $5.7 million in 2023, then decreased by 3.29% to $5.5 million in 2024, then declined by 2.62% to $5.4 million in 2025, then grew by 14.1% to $6.1 million in 2026.
- The last three Prepaid Assets figures came in at $6.1 million (Q1 2026), $5.4 million (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.14 Mn |
| Dec 31, 2025 | 5.38 Mn |
| Sep 30, 2025 | 4.50 Mn |
| Jun 30, 2025 | 7.33 Mn |
| Mar 31, 2025 | 5.15 Mn |
| Dec 31, 2024 | 5.53 Mn |
| Sep 30, 2024 | 6.64 Mn |
| Jun 30, 2024 | 7.59 Mn |
| Mar 31, 2024 | 5.43 Mn |
| Dec 31, 2023 | 5.72 Mn |
| Sep 30, 2023 | 8.49 Mn |
| Jun 30, 2023 | 7.87 Mn |
| Mar 31, 2023 | 9.70 Mn |
| Dec 31, 2022 | 6.23 Mn |
| Sep 30, 2022 | 8.31 Mn |
| Jun 30, 2022 | 7.69 Mn |
| Mar 31, 2022 | 7.52 Mn |
| Dec 31, 2021 | 9.67 Mn |
| Sep 30, 2021 | 14.75 Mn |
| Jun 30, 2021 | 16.73 Mn |